RE: Relentless selling means only one thing24 Apr 2024 14:59
None at all are, to my knowledge, neon. That is why I said I was disappointed that it has not happened, given everything that has gone on here.
I think that there have simply been too many unusual happenings here, not just the recent misleading information concerning those prescription numbers, which in itself was very serious, and IMO warranted regulatory scrutiny for that alone. Especially as the BOD have not followed up with their allegations against that third party, which they should have notified the market of by now.
As someone who has lost money here, but who gave the company the support and benefit of the doubt for quite some time, the lack of any update since the last RNS is the cherry on top really.
But not investment advice of course. Draw your own conclusions from all the previous RNS material and interviews, the fund raises, some of the historic share price movements just before certain events and where the company now sits, as far as we are currently aware. Perhaps you will draw a different conclusion. GLA anyway. Except the BOD.